ZLAB (STOCKS)
Zai Lab Limited American Depositary Shares
$25.900000
+0.410000 (+1.61%)
Prev close: $25.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ying Du
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,080.49M
- Employees
- 1,844
- P/E (TTM)
- -15.29
- P/B (TTM)
- 4.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
9
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.05 | $-0.07 | +0.0158 | +24.01% |
|
Mar 2026 (Q1)
|
$-0.05 | $-0.05 | -0.0021 | -4.38% |
|
Dec 2025 (Q4)
|
$-0.05 | $-0.07 | +0.0158 | +24.01% |
|
Sep 2025 (Q3)
|
$-0.03 | $-0.04 | +0.0144 | +32.43% |
Financial Statements
| Revenues | $449.61M |
| Benefits Costs and Expenses | $640.34M |
| Cost Of Revenue | $195.54M |
| Costs And Expenses | $640.34M |
| Gross Profit | $254.07M |
| Operating Expenses | $518.17M |
| Selling, General, and Administrative Expenses | $281.09M |
| Research and Development | $236.92M |
| Other Operating Expenses | $169.00K |
| Operating Income/Loss | -$264.10M |
| Income/Loss From Continuing Operations After Tax | -$188.21M |
| Income/Loss From Continuing Operations Before Tax | -$190.72M |
| Income Tax Expense/Benefit | -$2.51M |
| Net Income/Loss | -$188.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$188.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$188.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.17 |
| Diluted Earnings Per Share | -$0.17 |
| Basic Average Shares | 2,217,901,890 |
| Diluted Average Shares | 2,217,901,890 |
| Assets | $1.07B |
| Current Assets | $914.04M |
| Inventory | $90.89M |
| Other Current Assets | $823.15M |
| Noncurrent Assets | $160.76M |
| Fixed Assets | $46.43M |
| Intangible Assets | $85.77M |
| Other Non-current Assets | $28.55M |
| Liabilities | $467.76M |
| Current Liabilities | $428.58M |
| Accounts Payable | $136.69M |
| Wages | $23.76M |
| Other Current Liabilities | $268.13M |
| Noncurrent Liabilities | $39.17M |
| Equity | $607.04M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $607.04M |
| Liabilities And Equity | $1.07B |
| Net Cash Flow From Operating Activities | -$133.38M |
| Net Cash Flow From Operating Activities, Continuing | -$133.38M |
| Net Cash Flow From Investing Activities | -$39.05M |
| Net Cash Flow From Investing Activities, Continuing | -$39.05M |
| Net Cash Flow From Financing Activities | $44.64M |
| Net Cash Flow From Financing Activities, Continuing | $44.64M |
| Net Cash Flow | -$127.79M |
| Net Cash Flow, Continuing | -$127.79M |
| Comprehensive Income/Loss | -$219.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$234.35M |
| Other Comprehensive Income/Loss | -$168.74M |